Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Incyte Corporation

DE, United States

CMS manufacturer 100000000263

Open in the dashboard

General payments

$78,136,710

358,929 payments

Research payments

$477,247,475

186,139 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Incyte Corporation reported paying $78,136,710 in general payments and $477,247,475 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $13,874,323 91,367
2025 Research $83,416,167 32,691
2024 General $13,103,674 77,737
2024 Research $71,302,762 31,883
2023 General $14,516,991 72,085
2023 Research $61,052,850 21,954
2022 General $22,062,823 67,539
2022 Research $57,118,861 19,814
2021 General $6,722,963 29,897
2021 Research $53,299,684 20,038
2020 General $3,251,445 7,713
2020 Research $67,922,952 24,769
2019 General $4,604,490 12,591
2019 Research $83,134,199 34,990

Breakdown

Top recipients General payments · program year 2025
  1. Serge Alexanian Anatomic Pathology & Clinical Pathology · Los Angeles, CA $482,934 39 payments
  2. Hospital Of The Univ Of Penna Teaching hospital · PA $226,504 10 payments
  3. Ahmed Galal Hematology · Morristown, NJ $125,449 93 payments
  4. Raja Sivamani Dermatology · Sacramento, CA $116,795 98 payments
  5. Shahram Mori Hematology & Oncology · Orlando, FL $115,530 110 payments
  6. Sandra Rebish Dermatology · Upland, CA $111,032 9 payments
  7. Salman Fazal Hematology & Oncology · Pittsburgh, PA $108,783 118 payments
  8. Usama Gergis Hematology & Oncology · Allentown, PA $105,851 107 payments
  9. Ohsu Hospital And Clinics Teaching hospital · OR $103,337 4 payments
  10. Mohamad Khair Khasawneh Hematology & Oncology · Maywood, IL $101,531 125 payments
Top research recipients Research payments · program year 2025
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $3,845,546 801 payments
  2. City Of Hope National Medical Ctr Teaching hospital · CA $3,188,449 642 payments
  3. Covance Clinical Research $2,575,422 16 payments
  4. Hospital Of The Univ Of Penna Teaching hospital · PA $2,317,413 141 payments
  5. Hackensack University Medical Center Teaching hospital · NJ $2,222,886 657 payments
  6. Sarah Cannon Research Institue At Healthone $1,860,627 679 payments
  7. Stanford Cancer Ctr $1,855,804 659 payments
  8. Mount Sinai Doctors $1,683,900 430 payments
  9. Dana-Farber/ Mass General $1,661,489 95 payments
  10. Valkyrie Clinical Trials $1,383,156 574 payments
Products the payments named General payments · program year 2025
  1. Opzelura Dermatology $5,133,710 48% · 12,584 recipients
  2. Jakafi Hematology/Oncology $1,857,404 17% · 6,526 recipients
  3. Monjuvi Oncology $1,414,266 13% · 5,288 recipients
  4. Niktimvo Oncology $1,102,138 10% · 2,354 recipients
  5. Zynyz Oncology $899,033 8% · 3,313 recipients

The top 5 of 7 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $3,940,937 31% · 4,496 practitioners
  2. Hematology & Oncology Internal Medicine $3,095,175 24% · 2,725 practitioners
  3. Medical Oncology Internal Medicine $1,167,620 9% · 764 practitioners
  4. Physician Assistant $758,179 6% · 4,106 practitioners
  5. Anatomic Pathology & Clinical Pathology Pathology $484,818 4% · 31 practitioners

The top 5 of 143 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $2,001,644 14% · 2,607 recipients
  2. New York $1,231,771 9% · 1,907 recipients
  3. Texas $1,171,299 8% · 2,065 recipients
  4. Florida $1,076,802 8% · 2,314 recipients
  5. Pennsylvania $783,341 6% · 834 recipients

The top 5 of 52 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $29,682,833 12,236 payments
  2. Acquisitions $17,042,749 6 payments
  3. Consulting Fee $13,619,303 4,325 payments
  4. Food and Beverage $8,134,015 313,419 payments
  5. Travel and Lodging $5,269,054 18,746 payments
  6. Grant $1,451,431 37 payments
  7. Space rental or facility fees (teaching hospital only) $1,344,508 516 payments
  8. Education $1,237,344 9,628 payments
  9. Royalty or License $297,318 12 payments
  10. Charitable Contribution $56,400 3 payments
358,929 general · 186,139 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record